According to SEC filings for the period ending September 2025, Theravance Biopharma, Inc. (NASDAQ:TBPH) is held by 160 institutional firms.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| Madison Avenue Partners, LP | 30 Sep, 2025 | 9,511,150 | 0 | 0.00% | $138,862,790.00 |
| Weiss Asset Management LP | 30 Sep, 2025 | 7,457,060 | 0 | 0.00% | $108,873,076.00 |
| Newtyn Management, LLC | 30 Sep, 2025 | 4,950,000 | 0 | 0.00% | $72,270,000.00 |
| BlackRock, Inc. | 30 Sep, 2025 | 4,068,994 | -70,031 | -1.69% | $59,407,312.00 |
| Irenic Capital Management LP | 30 Sep, 2025 | 2,760,948 | 0 | 0.00% | $40,309,841.00 |
| VANGUARD GROUP INC | 30 Sep, 2025 | 2,211,582 | 54,152 | 2.51% | $32,289,097.00 |
| Park West Asset Management LLC | 30 Sep, 2025 | 1,284,081 | -515,000 | -28.63% | $18,747,583.00 |
| D. E. Shaw & Co., Inc. | 30 Sep, 2025 | 1,209,312 | 207,546 | 20.72% | $17,655,955.00 |
| Oasis Management Co Ltd. | 30 Sep, 2025 | 1,118,935 | 0 | 0.00% | $16,336,451.00 |
| ACADIAN ASSET MANAGEMENT LLC | 30 Sep, 2025 | 1,089,381 | 780,729 | 252.95% | $15,899.00 |
| STATE STREET CORP | 30 Sep, 2025 | 1,055,905 | 20,257 | 1.96% | $15,416,213.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 30 Sep, 2025 | 897,990 | 4,007 | 0.45% | $13,113,478.00 |
| DIMENSIONAL FUND ADVISORS LP | 30 Sep, 2025 | 766,704 | 44,634 | 6.18% | $11,193,148.00 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 30 Sep, 2025 | 726,783 | 505,314 | 228.16% | $10,611,032.00 |
| MORGAN STANLEY | 30 Sep, 2025 | 599,551 | 48,944 | 8.89% | $8,753,444.00 |
| BANK OF AMERICA CORP /DE/ | 30 Sep, 2025 | 527,107 | -12,538 | -2.32% | $7,695,763.00 |
| UBS Group AG | 30 Sep, 2025 | 514,170 | 117,037 | 29.47% | $7,506,883.00 |
| Assenagon Asset Management S.A. | 30 Sep, 2025 | 414,715 | 390,735 | 1,629.42% | $6,054,839.00 |
| BNP PARIBAS FINANCIAL MARKETS | 30 Sep, 2025 | 373,600 | -13,872 | -3.58% | $5,454,560.00 |
| MARSHALL WACE, LLP | 30 Sep, 2025 | 357,651 | 256,873 | 254.89% | $5,221,705.00 |